The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Phase I SBIR Grant Entitled “Inhibitors of the PHD2 Zinc Finger to Treat Anemia,” Jay Wrobel, Principal Investigator, in collaboration with Prof. Frank Lee of the University of Pennsylvania
Doylestown, PA. March 3, 2017- FCCDC is pleased to announce that it has been awarded a Phase I SBIR grant entitled “Inhibitors of the PHD2 Zinc Finger to Treat Anemia” (R43 HL137458-01), Jay Wrobel, Principal Investigator, in collaboration with Prof. Frank Lee of the University of Pennsylvania.